Проблема мотивации и ее нарушений при шизофрении (список литературы)
1. Addington J. Cognitive functioning and negative symptoms in schizophrenia // Cognition in Schizophrenia / T.Sharma, P.D.Harvey (Eds.). New York, NY: Oxford University Press, 2000. P. 193-209.
2. Andreasen N.C. Negative symptoms in schizophrenia. Definition and reliability // Arch. Gen. Psychiatry. 1982. Vol. 39. P. 784-788. Anthony W.A., Rogers E.S., Cohen M., Davies R.R. Relationships between psychiatric symptomatology, work skills and future vocational performance // Psychiatr. Serv. 1995. Vol. 46. P. 353-358.
3. Bandura A. Toward a psychology of human agency // Perspect. Psychol. Sci. 2006. Vol. 1. P. 164-180.
4. Barch D.M., Dowd E.C. Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions // Schizophr. Bull. 2010. June 21, doi:1 0.1 093 /schbul/sbq068/
5. Barch D.M., Yodkovik N., Sypher-Locke H., Hanewinkel M. Intrinsic motivation in schizophrenia: Relationships to cognitive function, depression, anxiety and personality // J. Abnorm. Psychol. 2008. Vol. 117. P. 776-787.
6. Barch D.M. The relationships among cognition, motivation and emotion in schizophrenia: How little we know // Schizophr. Bull.
2005. Vol. 31. P. 875-881.
7. Bateman T.S., Crant J.M. Revisiting intrinsic and extrinsic motivation // Paper presented at: Meeting of the Academy of Management; August 2003; Seattle, WA. http://www.commerce.virginia.edu/ faculty_research/facultydirectory/documents/IntrinsicJPSP.pdf. Accessed August 15, 2009.
8. Bell M.D., Mishara A.L. Does negative symptom change relate to neurocognitive change in schizophrenia? Implications for targeted treatments // Schizophr. Res. 2006. Vol. 81. P. 17-27.
9. Berridge K.C., Kringelbach M.L.Affective neuroscience of pleasure: reward in humans and animals // Psychopharmacology. 2008. Vol. 199. P. 457-480.
10. Berridge K.C. Motivation concepts in behavioral neuroscience // Physiol. Behav. 2004. Vol. 81. P. 179-209.
11. Bilder R.M., Mukherjee S., Rieder R.O., Pandurangi A.K. Symptomatic and neuropsychological components of defect states // Schizophr. Bull. 1985. Vol.11. P. 409-417.
12. Blanchard J.J., Horan W.P., Collins L.M. Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia? // Schizophr. Res. 2005. Vol. 77. P. 151-165.
13. Bleuler E. Dementia Praecox or the Group of Schizophrenias. NY: International Universities Press, 1950.
14. Bowie C.R., Reichenberg A., Patterson T.L. et al. Determinants of real world functional performance in schizophrenia subjects: Correlations with cognition, functional capacity and symptoms // Am. J. Psychiatry.
2006. Vol. 163. P. 418-425.
15. Boydell K.M., Gladstone B.M., Volpe T. Interpreting narratives of motivation and schizophrenia: A biopsychosocial understanding // Psychiatr. Rehab. J. 2003. Vol. 26. P. 422-426.
16. Burgdorf J., Panksepp J. The neurobiology of positive emotions // Neurosci. Biobehav. Rev. 2006. Vol. 30. P. 173-187.
17. Carey K.B., Carey M.P., Maisto S.A., Purnine D.M. The feasibility of enhancing psychiatric outpatients’ readiness to change their substance use // Psychiatr. Serv. 2002. Vol. 53. P. 602-608.
18. Carey K.B., Purnine D.M., Maisto S.A., Carey M.P. Enhancing readiness to change substance abuse in persons with schizophrenia. A four session motivation based intervention // Behav. Modif. 2001. Vol. 25. P. 331-384.
19. Carpenter W.T., Gold J.M. Another view of therapy for cognition in schizophrenia // Biol. Psychiatry. 2002. Vol. 52. P. 969-971.
20. Carpenter W.T., Heinrichs D.W., Wagman A.M. Deficit and nondeficit forms of schizophrenia: the concept // Am. J. Psychiatry. 1988. Vol. 145. P. 578-583.
21. Carver C.S., White T. Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: the BIS/BAS scales // J. Pers. Soc. Psychol. 1994. Vol. 67. P. 319-333.
22. Choi J., Mogami T., Medalia A. Intrinsic Motivation Inventory (IMI): an adapted scale for schizophrenia research // Schizophr. Bull. 2009. doi:10.1093/schbul/sbp030.
23. Choi J., Fiszdon J.M., Medalia A. Expectancy-value theory and persistence of learning effects: How perceived competency impacts learning in schizophrenia // Schizophr. Bull. 2010. doi:10.1093/ schbul/sbq078.
24. Crow T. Molecular pathology of schizophrenia: more than one disease process? // BMJ. 1980. Vol. 280. P. 1-9.
25. Gard D.E., Fisher M., Garrett C. et al. Motivation and its relationship to neurocognition, social cognition, and functional outcome in schizophrenia // Schizophr. Res. 2009. Vol. 115, N 1. P. 74-81. Epub 2009 Sep. 23.
26. Deci E.L., Ryan R.M. Facilitating optimal motivation and psychological wellbeing across life’s domains // Can. Psychol. 2008.
Vol. 49. P. 14-23.
27. Deci E.L., Ryan R.M. The ‘‘what’’ and ‘‘why’’ of goal pursuits: human needs and the self-determination of behavior // Psychol. Inq. 2000. Vol. 11. P. 227-268.
28. Dweck C.S., Master A. Self-theories motivate self-regulated learning // Motivation and self-regulated learning: Theory, research, and applications / D.H.Schunk, J.Barry (Eds.). Vol. xi. Mahwah, NJ: Lawrence Erlbaum Associates, 2008.
29. Dweck C.S. Self-theories: Their role in motivation, personality, and development. New York, NY: Psychology Press, 1999.
30. Eisenberger R., Rhoades L. Incremental effects of reward on creativity // J. Pers. Soc. Psychol. 2001. Vol. 81. P. 728-741.
31. Engelmann J.B., Damaraju E., Pademala S., Pessoa L. Combined effects of attention and motivation on visual task performance: transient and sustained motivational effects // Front. Hum. Neurosci. 2009. Vol. 3. P. 4.
32. Ferdinandi A.D., Yoottanasumpun V, Pollack S., Bermanzohn P.C. Predicting rehabilitation outcome among patients with schizophrenia // Psychiatr. Serv. 1998. Vol. 49. P. 907-909.
33. Fogel B.S. A neuropsychiatric approach to impairment of goal directed behavior // Am. Psychiatr. Press. Rev. Psychiatry. 1996. Vol.
15. P. 163-173.
34. Fowles D.C. A motivational theory of psychopathology. Lincoln (NE): University of Nebraska Press, 1994.
35. Fujii D.E., Wylie A.M. Neurocognition and community outcome in schizophrenia: long-term predictive validity // Schizophr. Res. 2002. Vol. 59. P. 219-223.
36. Gard D.E., Kring A.M., Gard M.G. et al. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure // Schizophr. Res. 2007. Vol. 93. P. 253-260.
37. Green M.F., Kern R.S., Braff D.L., Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the ‘‘right stuff’’? // Schizophr. Bull. 2000. Vol. 26. P. 119-136.
38. Green M.F., Penn D.L., Bentall R. Social cognition in schizophrenia: an NIMH Workshop on definitions, assessment, and research opportunities // Schizophr. Bull. [published online ahead of print January 08, 2008]. doi:10.1093/schbul/sbm145.
39. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia? // Am. J. Psychiatry. 1996. Vol. 153. P. 321-330.
40. Hall J., Harris J.M., McKirdy J.W. et al. Emotional memory in schizophrenia // Neuropsychologia. 2007. Vol. 45. P. 1152-1159.
41. Harvey P.D., Koren D., Reichenberg A., Bowie C.R. Negative symptoms and cognitive deficits: what is the nature of their relationship? // Schizophr. Bull. 2006. Vol. 32. P. 250-258.
42. Heggestad E., Kanfer R. Individual differences in trait motivation: development of the Motivational Trait Questionnaire // Int. J. Educ. Res. 2000. Vol. 33. P. 751-776.
43. Heinrichs D.W., Hanlon T.E., Carpenter W.T. Jr. The quality of life scale: An instrument for rating the schizophrenic deficit syndrome // Schizophr. Bull. 1984. Vol. 10. P. 388-398.
44. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficit in schizophrenia. A quantitative review of the evidence // Neuropsychology. 1998. Vol. 12. P. 426-445.
45. Ho B.C., Nopoulos P., Flaum M. et al. Two-year outcome in firstepisode schizophrenia: predictive value of symptoms for quality of life // Am. J. Psychiatry. 1998. Vol. 155. P. 1196-1201.
46. Horan W.P., Green M.F., Kring A.M., Neuchterlein K.H. Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions? // J. Abnorm. Psychol. 2007. Vol. 102. P. 507-517.
47. Horan W.P., Kring A.M., Blanchard J.J. Anhedonia in schizophrenia: a review of assessment strategies // Schizophr. Bull. 2006. Vol. 32. P. 259-273.
48. Jackson J.H. Selected Writings. New York, NY: Basic Books, 1958.
49. Kimhy D., Yale S., Goetz R.R. et al. The factorial structure of the schedule for the deficit syndrome in schizophrenia // Schizophr. Bull.
2006. Vol. 32. P. 274-278.
50. Kirkpatrick B., Buchanan R.W., Ross D.E. et al. A separate disease within the syndrome of schizophrenia // Arch. Gen. Psychiatry. 2001. Vol. 58. P. 165-171.
51. Klein D. Depression and anhedonia // Anhedonia and affect deficit states / D.C.Clark (Ed.). New York, NY: PMA Publishing, 1984. P. 1-14.
52. Lehman A.F., Kreyenbuhl J., Buchanan R.W. et al. The Schizophrenia Patient Outcomes Research Team (PORT): Updated treatment recommendations 2003 // Schizophr. Bull. 2004. Vol. 30. P. 193-217.
53. Liddle P.F. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy // Br. J. Psychiatry. 1987. Vol. 151. P. 145-151.
54. Locke H.S., Braver T.S. Motivational influences on cognitive control: behavior, brain activation, and individual differences // Cogn. Affect. Behav. Neurosci. 2008. Vol. 8. P. 99-112.
55. Maller O. A Motivation Evaluating Rating Scale for chronic impaired schizophrenics (MERS) // Psychiatria Clin. 1974. Vol. 7. P. 347-357.
56. Matthews J.R., Barch D.M. Episodic memory for emotional and nonemotional words in schizophrenia // Cogn. Emot. 2004. Vol. 18. P. 721-740.
57. Medalia A., Richardson R. What predicts a good response to cognitive remediation interventions? // Schizophr. Bull. 2005. Vol. 31. P. 942-953.
58. Mee J., Sumsion T. Mental health clients confirm the motivating power of occupation // Br. J. Occup. Ther. 2001. Vol. 64. P. 121-128.
59. Milev P., Ho B.C., Arndt S., Andreasen N.C. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up // Am. J. Psychiatry. 2005. Vol. 162. P. 495-506.
60. Moller H.J., Muller H., Borison R.L. et al. A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A reevaluation of the North American risperidone study // Eur. Arch. Psychiatry Clin. Neurosci. 1995. Vol. 245. P. 45-49.
61. Mueser K.T., Sayers S.L., Schooler N.R. et al. A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms // Am. J. Psychiatry. 1994. Vol. 151. P. 1453-1462.
62. Nakagami E., Hoe M., Brekke J.S. The prospective relationships among intrinsic motivation, neurocognition, and community functioning in schizophrenia // Schizophr. Bull. 2010. doi:10.1093/ schbul/sbq043.
63. Nakagami E., Xie B., Hoe M., Brekke J.S. Intrinsic motivation, neurocognition and psychosocial functioning in schizophrenia: Testing mediator and moderator effects // Schizophr. Res. 2008. Vol. 105. P. 95-104.
64. Pecina S., Smith K.S., Berridge K.C. et al. Hedonic hot spots in the brain // Neuroscientist. 2006. Vol. 12. P. 500-511.
65. Peralta V., Cuesta M.J. Dimensional structure of psychotic symptoms: an item-level analysis of SAPS and SANS symptoms in psychotic disorders // Schizophr. Res. 1999. Vol. 38. P.13-26.
66. Perlick D.A., Rosenheck R.A., Kaczynski R. et al. Association of symptomatology and cognitive deficits to functional capacity in schizophrenia // Schizophr. Res. 2008. Vol. 99. P. 192-199.
67. Richardson D.K., Reynolds S.M., Cooper S.J., Berridge K.C. Endogenous opioids are necessary for benzodiazepine palatability enhancement: naltrexone blocks diazepam-induced increase of sucrose-liking’ // Pharmacol. Biochem. Behav. 2005. Vol. 81. P. 657-663.
68. Riechenberg A., Harvey P.D. Neuropsychological impairments in schizophrenia: integration of performance-based and brain imaging findings // Psychol. Bull. 2007. Vol. 133. P. 833-858.
69. Robinson D.G., Woerner M.G., McMeniman M. et al. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder // Am. J. Psychiatry. 2004. Vol. 161. P. 473-479.
70. Rosenheck R., Leslie D., Keefe R. Barriers to employment for people with schizophrenia // Am. J. Psychiatry. 2006. Vol. 163. P. 411-417.
71. Ryan R.M., Deci E.L. Intrinsic and extrinsic motivation: classic definitions and new directions // Contemp. Educ. Psychol. 2000. Vol.
25. P. 54-67.
72. Ryan R.M., Deci E.L. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being // Am. Psychol. 2000. Vol. 55. P. 68-78.
73. Sass L.A., Parnas J. Schizophrenia, consciousness, and the self // Schizophr. Bull. 2003. Vol. 29. P. 427-444.
74. Sayers S.L., Curran P.J., Mueser K.T. Factor structure and construct validity of the scale for the assessment of negative symptoms // Psychol. Assessment. 1996. Vol. 8. P. 269-280.
75. Schmand B., Kuipers T., Van der Gaag M. et al. Cognitive disorders and negative symptoms as correlates of motivational deficits in psychotic patients // Psychol. Med. 1994. Vol. 24. P. 869-884.
76. Schooler N.R. Relapse prevention and recovery in the treatment of schizophrenia // J. Clin. Psychiatry. 2006. Vol. 67, Suppl. 5. P. 19-23.
77. Schunk D.H., Zimmerman B.J. Motivation and self-regulated learning: theory, research, and applications. Mahwah, NJ: Lawrence Erlbaum Associates Publishers, 2008.
78. Sharma T., Antonova L. Cognitive function in schizophrenia: deficits, functional consequences, and future treatment // Psychiatr. Clin. North. Am. 2003. Vol. 26. P. 25-40.
79. Silverstein S.M. Bridging the gap between extrinsic and intrinsic motivation in the cognitive remediation of schizophrenia // Schizophr. Bull. 2010. doi:10.1093/schbul/sbp160.
80. Smith K.S., Berridge K.C., Smith K.S. Opioid limbic circuit for reward: interaction between hedonic hotspots of nucleus accumbens and ventral pallidum // J. Neurosci. 2007. Vol. 27. P. 1594-1605.
81. Strauss J.S., Carpenter W.T.Jr, Bartko J.J. The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs // Schizophr. Bull. 1974. Vol. 11. P. 61-69.
82. Summerfelt A.T., Alphs L.D., Funderburk F.R. et al. Impaired Wisconsin card sort performance in schizophrenia may reflect motivational deficits // Arch. Gen. Psychiatry. 1991. Vol. 48. P. 282-283.
83. Tollefson G.D., Sanger T.M. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine // Am. J. Psychiatry. 1997. Vol. 154. P. 466-474.
84. Wigfield A., Eccles J.S. Expectancy-value theory of achievement motivation // Contemp. Educ. Psychol. 2000. Vol. 25. P. 68-81.